Biomedicine and Covid-19 from gene to industry

The current global crisis caused by the SARS-CoV-2 Coronavirus has affected more than 3 million inhabitants globally and has set governments in motion to implement public policies aimed at preventing the spread of the virus. For their part, the scientific community and the pharmaceutical industry are working to find solutions for timely diagnosis, the search for therapeutic drugs and the generation of vaccines that prevent the COVID19 disease and the spread of the virus by generating immunity in the population.

In this series of webinars we want to bring the VedasCII community closer to biomedical research in a multidisciplinary way from the identification of the infectious agent to the production of vaccines against SARS-CoV-2.